A 64-year-old woman presents with recurrent apical prolapse, mixed incontinence and urgency that has not responded to two anticholinergics. Her previous surgeon did everything by the book. She still leaks, and she wants to know what happens next.
Cases like this are where basic urogynecology ends and advanced urogynecology begins. The answers are rarely one-size-fits-all, and the best decisions rest on trial evidence, careful counselling and a clear view of what each patient values. This guide walks through the questions that matter most for specialists and gynecologists with an interest in female pelvic medicine.
At a Glance: Common Dilemmas and Evidence-Informed Responses
Clinical dilemma
Evidence-informed approach
Key evidence
Is urodynamics needed before surgery for stress incontinence?
Not routinely in uncomplicated stress incontinence; useful in mixed, recurrent, neurological or voiding-dysfunction cases
VALUE trial
Add a sling at prolapse repair in a continent woman?
Discuss benefit versus added risk; consider selective or staged approach
CARE and OPUS trials
Best vaginal route for apical support?
Uterosacral and sacrospinous fixation show similar outcomes at 2 years
OPTIMAL trial
Retropubic or transobturator sling?
Similar long-term success; adverse-event profiles differ
TOMUS trial
Refractory overactive bladder: botulinum toxin or neuromodulation?
Both effective; trade-offs between infection and catheterisation risk and device-related issues
ROSETTA trial
Recurrent UTI prevention without daily antibiotics?
Methenamine hippurate and vaginal estrogen (postmenopausal) are evidence-supported options
ALTAR trial
1. Urodynamics: When It Changes Management
The VALUE trial showed that, in women with uncomplicated stress urinary incontinence, an office evaluation was not inferior to urodynamic testing before surgery. This changed the question from "Should every patient have urodynamics?" to "Which patients will urodynamics help?"
Testing remains valuable when symptoms are mixed or unclear, when there is prior incontinence surgery, voiding difficulty, a neurological condition, or a prolapse that may mask incontinence. In those settings, it can alter the plan or the counselling, which is the real test of whether a test is worth doing.
2. Occult Stress Incontinence and the Sling Question at Prolapse Surgery
Many women with prolapse become incontinent after repair when the descent no longer kinks the urethra. The CARE trial found that adding a Burch colposuspension at abdominal sacrocolpopexy reduced postoperative stress incontinence in continent women. The OPUS trial found that a mid-urethral sling at vaginal prolapse surgery reduced later incontinence, but at the cost of additional adverse events.
The practical message is shared decision-making. Describe the risk of new incontinence, the benefit of a concomitant procedure and the option of a staged approach, then let the patient's priorities guide the plan.
3. Apical Support: Choosing the Route
Apical support is the foundation of durable prolapse repair. Several points shape the decision:
Sacrocolpopexy is associated with lower recurrence than vaginal apical fixation in many comparisons, but it involves a longer operation and mesh-related risks, and it requires an abdominal approach (open, laparoscopic or robotic).
Vaginal native-tissue repairs avoid mesh. In the OPTIMAL trial, uterosacral ligament suspension and sacrospinous ligament fixation had similar surgical outcomes at two years, and adding perioperative pelvic floor muscle training did not change the primary outcome.
Transvaginal mesh for prolapse has been withdrawn from the US market, so counselling should be clear about the difference between that and abdominal sacrocolpopexy mesh.
Surgeon expertise, patient age, activity, prior surgery and comorbidity should shape the route more than technology alone.
4. Hysteropexy or Hysterectomy?
Many women prefer to keep the uterus. Randomised data, including the VUE trial comparing sacrospinous hysteropexy with vaginal hysterectomy and uterosacral suspension, suggest that uterine preservation can achieve comparable prolapse outcomes in carefully selected patients at medium-term follow-up.
Not every woman is a candidate. Abnormal bleeding, cervical pathology, elongated cervix and future screening needs all matter. Document that the option was discussed.
5. Slings Revisited: Retropubic or Transobturator?
The mid-urethral sling remains a well-studied operation for stress incontinence. In the TOMUS trial, retropubic and transobturator slings had similar success at long-term follow-up, but different adverse events, with voiding dysfunction more typical of retropubic slings and groin or thigh pain more typical of transobturator slings.
Use that profile when counselling. Also review the evidence base before adopting single-incision devices, which have a thinner and more mixed record.
6. Refractory Overactive Bladder: Beyond First- and Second-Line
After behavioural therapy and medication, advanced options include intradetrusor onabotulinumtoxinA, sacral neuromodulation and tibial nerve stimulation. In the ROSETTA trial, botulinum toxin gave a slightly greater reduction in urgency incontinence episodes than sacral neuromodulation but carried higher rates of urinary tract infection and need for catheterisation.
Anticholinergic burden deserves attention in older women. Observational studies have raised concern about cognitive effects, and this is one reason beta-3 agonists and non-drug options are used more widely. Before botulinum toxin, make sure the patient is willing and able to perform intermittent self-catheterisation if needed.
7. Recurrent UTIs: Reducing Antibiotic Dependence
Confirm infections with culture, evaluate for incomplete emptying, prolapse, stones and other contributors, and treat modifiable factors. For prevention, the ALTAR trial found methenamine hippurate to be non-inferior to daily low-dose antibiotic prophylaxis in women with recurrent UTI, with similar infection rates over a year. In postmenopausal women, vaginal estrogen has good supporting evidence. Evidence for several popular supplements is weak, and a large randomised trial of D-mannose did not show a benefit over placebo.
8. Obstetric Anal Sphincter Injury and Long-Term Pelvic Floor Health
Urogynecology is also prevention. Early recognition and repair of obstetric anal sphincter injury, structured postpartum follow-up and counselling about future deliveries reduce long-term morbidity. Referral pathways to pelvic floor physiotherapy and colorectal or urogynecology services are as important as surgical skill.
9. Measure What Matters to the Patient
Outcomes in urogynecology are about function and quality of life, not just anatomy. Validated patient-reported tools such as the PFDI-20 for symptoms and the PISQ-12 for sexual function help clinicians track results and set realistic expectations. Pair them with objective measures where appropriate and review outcomes in your own practice.
How to Keep Building Advanced Skills
Advanced pelvic floor care requires more than reading trials. It needs structured learning, case discussion and supervised practice. If you want to deepen your expertise, explore the Fellowship in Urogynecology for doctors.
Frequently Asked Questions
What is advanced urogynecology? It refers to the evaluation and management of complex pelvic floor disorders, including recurrent prolapse, mixed incontinence, refractory overactive bladder, mesh complications and obstetric injury, often involving surgery or specialised therapies.
Is urodynamics necessary before every incontinence surgery? No. In uncomplicated stress incontinence, an office evaluation can be sufficient. Urodynamics is more useful in mixed, recurrent, neurological or unclear cases.
Is sacrocolpopexy better than vaginal repair for apical prolapse? Sacrocolpopexy is associated with lower recurrence in many comparisons, but vaginal native-tissue repair avoids mesh and a longer abdominal operation. The choice depends on the patient and the surgeon's experience.
Can the uterus be preserved during prolapse surgery? In carefully selected women, hysteropexy can offer outcomes comparable to hysterectomy at medium-term follow-up, according to randomised data.
How can recurrent UTIs be prevented without long-term antibiotics? Options include methenamine hippurate and, in postmenopausal women, vaginal estrogen, along with treating underlying contributors.
Conclusion
Advanced urogynecology is about matching the right intervention to the right patient, backed by evidence and a frank discussion of trade-offs. Clinicians who understand the trials behind their choices make better decisions and give patients clearer expectations.



